Log In
Print this Print this

dolutegravir (Tivicay) (S/GSK1349572) (formerly S-349572)

Also known as: 1349572 (GSK1349572)

  Manage Alerts
Collapse Summary General Information
Company ViiV Healthcare Ltd.
DescriptionHIV integrase inhibitor
Molecular Target HIV integrase
Mechanism of ActionHIV integrase inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection; Treat HIV infection in patients ages 12 and over; Treat HIV-1 infection in treatment-experienced patients; Treat HIV-1 infection in treatment-naïve patients
Regulatory Designation

U.S. - Priority Review (Treat HIV infection in patients ages 12 and over);
EU - Standard Review (Treat HIV infection);
Japan - Orphan Drug (Treat HIV infection)


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today